Healthcare provider profile · identity verified

Arnold M Rey, MD

Family Practice · OROVILLE, CA · NPI 1245225440

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	551	180
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	529	71
Amlodipine Besylate	Amlodipine Besylate	447	129
Losartan Potassium	Losartan Potassium	414	117
Lisinopril	Lisinopril	390	118
Levothyroxine Sodium	Levothyroxine Sodium	357	102
Gabapentin	Gabapentin	348	101
Omeprazole	Omeprazole	342	109
Hydrochlorothiazide	Hydrochlorothiazide	296	82
Metformin Hcl	Metformin Hcl	269	75
Metoprolol Tartrate	Metoprolol Tartrate	264	79
Rosuvastatin Calcium	Rosuvastatin Calcium	250	71
Tamsulosin Hcl	Tamsulosin Hcl	215	66
Zolpidem Tartrate	Zolpidem Tartrate	175	36
Pantoprazole Sodium	Pantoprazole Sodium	169	49
Lorazepam	Lorazepam	165	39
Furosemide	Furosemide	160	50
Albuterol Sulfate Hfa	Albuterol Sulfate	159	47
Metoprolol Succinate	Metoprolol Succinate	139	41
Potassium Chloride	Potassium Chloride	128	46
Carvedilol	Carvedilol	127	32
Mirtazapine	Mirtazapine	123	32
Simvastatin	Simvastatin	119	31
Montelukast Sodium	Montelukast Sodium	117	34
Tramadol Hcl	Tramadol Hcl	115	26
Trazodone Hcl	Trazodone Hcl	115	33
Allopurinol	Allopurinol	110	27
Sertraline Hcl	Sertraline Hcl	109	26
Valsartan	Valsartan	102	30
Fluoxetine Hcl	Fluoxetine Hcl	88	23
Bupropion Xl	Bupropion Hcl	85	29
Ibuprofen	Ibuprofen	85	25
Duloxetine Hcl	Duloxetine Hcl	83	24
Escitalopram Oxalate	Escitalopram Oxalate	80	25
Alprazolam	Alprazolam	78	13
Meloxicam	Meloxicam	74	21
Synthroid	Levothyroxine Sodium	66	16
Clopidogrel	Clopidogrel Bisulfate	64	24
Buspirone Hcl	Buspirone Hcl	60	17
Fluticasone Propionate	Fluticasone Propionate	60	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	14
Ropinirole Hcl	Ropinirole Hcl	57	17
Quetiapine Fumarate	Quetiapine Fumarate	56	15
Citalopram Hbr	Citalopram Hydrobromide	53	16
Triamcinolone Acetonide	Triamcinolone Acetonide	52	21
Estradiol	Estradiol	50	11
Donepezil Hcl	Donepezil Hcl	48	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	13
Atenolol	Atenolol	47	16
Baclofen	Baclofen	46	14
Eliquis	Apixaban	45	14
Famotidine	Famotidine	45	11
Celecoxib	Celecoxib	44	13
Jardiance	Empagliflozin	44	12
Glipizide Er	Glipizide	43	11
Ventolin Hfa	Albuterol Sulfate	43	17
Aripiprazole	Aripiprazole	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Testosterone Cypionate	Testosterone Cypionate	34	suppressed
Spironolactone	Spironolactone	33	12
Temazepam	Temazepam	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Ozempic	Semaglutide	32	suppressed
Pregabalin	Pregabalin	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	12
Ezetimibe	Ezetimibe	30	12
Farxiga	Dapagliflozin Propanediol	30	suppressed
Glipizide	Glipizide	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Finasteride	Finasteride	29	suppressed
Naproxen	Naproxen	29	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Propranolol Hcl	Propranolol Hcl	26	suppressed
Repatha Sureclick	Evolocumab	26	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Dexlansoprazole Dr	Dexlansoprazole	23	suppressed
Diazepam	Diazepam	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Prednisone	Prednisone	20	15
Terbinafine Hcl	Terbinafine Hcl	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Cephalexin	Cephalexin	18	13
Prochlorperazine Maleate	Prochlorperazine Maleate	18	suppressed
Azithromycin	Azithromycin	17	15
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Febuxostat	Febuxostat	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Felodipine Er	Felodipine	14	suppressed
Metaxalone	Metaxalone	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Serevent Diskus	Salmeterol Xinafoate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Lactulose	Lactulose	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error